NANDRO P (NPP) Aslan Pharma USA

NANDRO P (NPP) Aslan Pharma USA

Active Substance: Nandrolone Phenylpropionate

Manufacturer: Aslan Pharma USA

Pack: 10 ml Vial x 100 mg/ml

Form: Injectable

What Is Nandrolone Phenylpropionate (NPP)?

Nandrolone Phenylpropionate (NPP), often known by its trade name Durabolin, is the short-ester version of Nandrolone (19-nortestosterone). It is an injectable anabolic component highly valued for its strong anabolic effects and ability to enhance strength and produce lean muscle mass with reduced water retention compared to its long-ester counterpart, Deca-Durabolin.

Key Characteristics

Note on Speed: NPP provides a sharp spike in Nandrolone release 24–48 hours following injection. Its active life is approximately one week, which is significantly faster than the three-week active life of Nandrolone Decanoate. This rapid clearance is a key advantage.

Core Performance Benefits

• High Anabolic Power: With a rating of 125, NPP is highly effective for measurable strength and lean mass gains.

• Rapid Action: The fast release allows users to feel the effects quickly and makes dosage adjustments easier.

• Minimal Water Retention: Compared to the Decanoate ester, NPP results in less water retention, promoting a cleaner, harder look.

• Therapeutic Joint Relief: Like all Nandrolone compounds, NPP provides excellent support for joint and tendon health by promoting collagen synthesis.

Usage and Dosage Protocol

Due to the short Phenylpropionate ester, NPP requires frequent administration to maintain stable, effective blood levels.

• Injection Frequency: NPP should be injected at least once every 5 days (often every 3 days or EOD) to maintain stability. Injecting once a week is insufficient for this compound.

• Recommended Dosage (Men): 200–400 mg weekly is the most commonly recommended dosage range for significant gains over a cycle duration of up to 12 weeks.

• Recommended Dosage (Women): 50–100 mg weekly is the recommended dosage for 6–8 week cycles.

Side Effects and Management

Nandrolone’s unique properties require proactive management, despite its low androgenic and estrogenic ratings.

• Prolactin Risk (Mandatory Management): The moderate Progestational Activity is the main concern. It can lead to elevated prolactin, causing libido suppression (“Deca Dick”) and potential prolactin-induced gynecomastia. Always stack NPP with a Testosterone base and keep a dopamine agonist (like Cabergoline) on hand.

• Androgenic Effects: Side effects are low but possible, including headache, acne, and increased sexual desires, particularly at high doses. Tension and nose-bleeding are also reported.

• Suppression: NPP is extremely suppressive to natural testosterone production. A comprehensive Post Cycle Therapy (PCT) is mandatory after the cycle ends.